# Ecological momentary insights into cannabis use and its contexts: a pre-post legalization … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/ecological-momentary-insights-into-cannabis-use-and-its-contexts-a-pre-post-legalization/ > **Published:** 2026-09-05T12:14:28-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:40-04:00 > **Clinical Summary:** Explore how cannabis use patterns and contexts change post-legalization, impacting adolescent neurodevelopment and psychosis risk. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthNeurologyPolicyResearchAgingSafetyPain Why This Matters This article matters for clinicians and their patients as it provides insights into cannabis use patterns before and after legalization, which can help in understanding the impact of legalization on adolescent cannabis use and potential associated risks such as psychosis. These findings are crucial for informing evidence-based clinical practices and interventions related to substance abuse prevention and treatment. Clinical Summary This article presents ecological momentary assessment data on cannabis use patterns and contexts before and after legalization, highlighting potential changes in adolescent cannabis use. The findings suggest a shift towards more frequent and public consumption post-legalization, which may have implications for clinicians managing patients with substance use disorders or mental health issues, as increased accessibility could potentially exacerbate these conditions. Clinicians should be aware of the evolving landscape of cannabis use and consider its potential impact on their patients’ health. Dr. Caplan’s Take “The findings from this study offer intriguing insights into the relationship between cannabis use and psychosis, particularly in adolescents. However, as a family physician specializing in cannabis medicine, I emphasize that while these results are promising, they need to be corroborated with further human studies before we can draw definitive conclusions about their implications for patient care.” Clinical Perspective 🔬 Embracing the findings from Rubino’s 2010 study on adolescent cannabis use and psychosis, healthcare providers should be cognizant of the complex relationship between cannabis consumption and mental health. The article, while not directly addressing legalization, highlights the potential risks associated with cannabis use during critical neurodevelopmental periods. In clinical practice, it’s crucial to consider individual factors such as age at onset, frequency, and potency of cannabis use when assessing patients for psychosis or related symptoms. Confounders like co-occurring substance use, family history of mental illness, and environmental stressors should also be taken into account. Practically, this means that healthcare providers should engage in open discussions about cannabis use with their patients, particularly adolescents, and provide education on potential risks, especially in the context of legalization where access may increase. Regular mental health screenings 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Ecological%20momentary%20insights%20into%20cannabis%20use%20and%20its%20contexts%3A%20a%20pre-post%20legalization%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90640)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90640)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Ecological%20momentary%20insights%20into%20cannabis%20use%20and%20its%20contexts%3A%20a%20pre-post%20legalization%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90640)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.nature.com/articles/s41598-026-70148-7](https://www.nature.com/articles/s41598-026-70148-7) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).